Medicare Enrolled
Dr. Cory Conniff, MD
Rheumatology · Orland Park, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Conniff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Conniff?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Conniff
Dr. Cory Conniff is a rheumatology specialist in Orland Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Conniff performed 103,658 Medicare services across 1,088 unique beneficiaries.
Between the years covered by Open Payments, Dr. Conniff received a total of $16,498 from 49 pharmaceutical and/or device companies across 812 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Conniff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in IL
$16,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗103,658
Medicare services
Top 9% in IL for rheumatology
1,088
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,183 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
48,820 | $10 | $81 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
36,800 | $4 | $28 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
6,925 | $34 | $180 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
4,825 | $13 | $150 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
944 | $96 | $249 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
449 | $109 | $350 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
260 | $68 | $333 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
215 | $61 | $160 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $24 | $98 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $65 | $187 |
| Injection, methylprednisolone acetate, 40 mg | 77 | $6 | $25 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
72 | $24 | $78 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
72 | $1 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $128 | $348 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $12 | $150 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
32 | $41 | $237 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
17 | $54 | $151 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
54.3% high complexity
44.7% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,498
Total received (2018-2024)
Avg $2,357/year across 7 years
Top 15% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
812
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,415 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,719
2023
$3,362
2022
$2,553
2021
$2,385
2020
$1,488
2019
$2,153
2018
$1,838
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$468
Janssen Biotech, Inc.
$263
ANI Pharmaceuticals, Inc.
$222
E.R. Squibb & Sons, L.L.C.
$180
Novartis Pharmaceuticals Corporation
$168
ABBVIE INC.
$166
Alexion Pharmaceuticals, Inc.
$162
Mallinckrodt Hospital Products Inc.
$152
Lilly USA, LLC
$147
PFIZER INC.
$146
GENZYME CORPORATION
$106
AstraZeneca Pharmaceuticals LP
$105
Octapharma USA, Inc.
$94
Fresenius Kabi USA, LLC
$89
SOBI, INC
$55
Genentech USA, Inc.
$50
Sandoz Inc.
$38
DePuy Synthes Sales Inc.
$30
Organon Llc
$29
Bioventus LLC
$25
UCB, Inc.
$24
Top 3 companies account for 35.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,474
Horizon Therapeutics plc
$1,614
Novartis Pharmaceuticals Corporation
$1,360
Janssen Biotech, Inc.
$1,274
E.R. Squibb & Sons, L.L.C.
$1,082
Lilly USA, LLC
$986
PFIZER INC.
$824
AbbVie Inc.
$667
Mallinckrodt Hospital Products Inc.
$517
AbbVie, Inc.
$497
UCB, Inc.
$491
ABBVIE INC.
$442
ANI Pharmaceuticals, Inc.
$428
Boehringer Ingelheim Pharmaceuticals, Inc.
$343
Genentech USA, Inc.
$336
US Oncology Corporate, Inc.
$314
Alexion Pharmaceuticals, Inc.
$288
AstraZeneca Pharmaceuticals LP
$247
Horizon Pharma plc
$225
GlaxoSmithKline, LLC.
$182
GENZYME CORPORATION
$178
Celgene Corporation
$165
TerSera Therapeutics LLC
$158
Fresenius Kabi USA, LLC
$116
Avanos Medical
$113
Antares Pharma, Inc.
$97
Takeda Pharmaceuticals U.S.A., Inc.
$96
Octapharma USA, Inc.
$94
DePuy Synthes Sales Inc.
$91
Actelion Pharmaceuticals US, Inc.
$89
SOBI, INC
$86
Sandoz Inc.
$84
Janssen Scientific Affairs, LLC
$69
Organon LLC
$68
Fidia Pharma USA Inc.
$47
Mallinckrodt Enterprises LLC
$46
Bioventus LLC
$41
Mallinckrodt LLC
$37
Organon Llc
$29
Radius Health, Inc.
$29
Hikma Pharmaceuticals USA
$27
Teva Pharmaceuticals USA, Inc.
$27
Celltrion USA Inc.
$24
Orthogenrx Inc.
$23
Sobi, Inc
$18
FIDIA PHARMA USA INC.
$15
Ferring Pharmaceuticals Inc.
$14
Aurinia Pharma U.S., Inc.
$12
Ironwood Pharmaceuticals, Inc
$12
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BEVESPI AEROSPHERE · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUZALLO · Durolane · ENTYVIO · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · GENVISC 850 SODIUM HYALURONATE · HADLIMA · HUMIRA · HYM/HYN · HYMOVIS · HYRIMOZ · Humira · Hymovis · IDACIO · ILARIS · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · OLUMIANT · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PANZYGA · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SUPARTZ FX SODIUM HYALURONATE · TALTZ · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · TriVisc sodium hyaluronate · Trintellix · Truxima · Tymlos · UPTRAVI · Uloric · XELJANZ · XYOSTED · YUFLYMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
131
Per 100K population
2.5
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
6.7 mi
6.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Conniff is a mixed practice specialist, with above-average Medicare volume (top 9% in IL), with low-engagement industry engagement in the top 15% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Conniff experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Conniff performed 48,820 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Conniff receive payments from pharmaceutical companies?
Yes. Dr. Conniff received a total of $16,498 from 49 companies across 812 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Conniff's costs compare to other rheumatologists in Orland Park?
Dr. Conniff's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Conniff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Orland Park
Browse rheumatologists in Orland Park ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in IL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in IL
Which IL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology